Drug resistant Mycobacterium tuberculosis, an analysis of the Dutch situation;Resistentie bij Mycobacterium tuberculosis in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 44, 1996, Pages 2187-2191

  Lambregts Van Weezenbeek, C S B ^a   Van Klingeren, B ^b   Veen, J ^a  

^a Koninklijke Nederlandse Ctrl V   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ARTICLE; HUMAN; IMMIGRATION; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS;

ANTIBIOTICS, ANTITUBERCULAR; ANTITUBERCULAR AGENTS; DRUG THERAPY, COMBINATION; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; NETHERLANDS; PREVALENCE; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0029823396     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Fischl M, Uttamchandani R, Reyes R, Cleary T, Otten J, Breeden A, et al. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York, 1988-1991. MMWR 1991;40:585-91.
2. Greifinger R, Keehfus C, Grabau J, Quinlan A, Loeder A, DiFerdinanco jr G, et al. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system - New York, 1991. MMWR 1992;41:507-9.
3. Hoch DE, Wilcox jr KR. Transmission of multidrug-ressstant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility - Michigan. MMWR 1991;40:129-31.
4. Grandes G, Lopez-de-Munain J, Diaz T, Rullan JV. Drug-resistant tuberculosis in Puerto Rico, 1987-1990. Am Rev Respir Dis 1993; 148:6-9.
5. Jain NK, Chopra KK, Prasad G. Initial and acquired isoniazid and rifampicin resistance to M. tuberculosis and its implications for treatment. Indian Journal of Tuberculosis 1992,39:121-4.
6. Trivedi SS, Desai SG. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988; 69:37-42.
7. Kim SJ, Hong YP. Drug resistance of Mycobacterium tuberculosis in Korea Tuber Lung Dis 1992;73:219-24.
8. Kochi A, Vareldzis B, Styblo K. Multidrug-resistant tuberculosis and its control. Res Microbiol 1993;144:104-10.
9. Rodier G, Gravier P, Sevre JP, Binson G, Omar CS. Multidrug-resistant tuberculosis in the Horn of Africa. J Infect Dis 1993,168:523-4.
10. Guidelines for surveillance of drug resistance in tuberculosis. Tuberculosis Programme World Health Organization (WHO), Geneva, and International Union Against Tuberculosis and Lung Disease, Paris. TB/94.178. Geneva: WHO, 1994.
11. Lambregts-van Weezenbeek CSB, Veen J. Control of drug-resistant tuberculosis. Tuber Lung Dis 1995;76:455-9.
12. Long R, Manfreda J, Mendella L, Wolfe J, Parker S, Hershfield E Antituberculous drug resistance in Manitoba from 1980 to 1989. Can Med Assoc J 1993;148.1489-95.
13. Nunn P, Felten M Surveillance of resistance to antituberculosis drugs in developing countries. Tuber Lung Dis 1994;75:163-7
14. Veen J, Kalisvaart NA, redacteuren. Index tuberculosis 1993 Nederland Den Haag: KNCV, 1994.
15. Snider jr DE, Simone PM, Dooley SW, Bloch AB. Multi-drug-resistant tuberculosis Sci Am 1994,270.16-25.
16. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144. 745-9.
17. Bloom BR, Murray CJL. Tuberculosis: commentary on a reemergent killer. Science 1992;257:1055-64.
18. Commissie voor Practische Tuberculosebestrijding, Beleid ten aanzien van risicogroepen voor tuberculose in Nederland. Den Haag: KNCV, 1995.
19. Commissie 'Multiresistente Tuberculose'. Richtlijnen met betrekking tot de behandeling en preventie van multiresistente tuberculose in Nederland. Den Haag: KNCV, 1993.
20. Initial therapy for tuberculosis in the era of multidrug resistance. Recommendations of the Advisory Council for the Eliminiation of Tuberculosis. MMWR 1993;42:1-8.
21. Veen J. Kortere behandeling van longtuberculose alleen acceptabel bij minstens 4 middelen in de mitiële combinatie van tuberculostatica. Ned Tijdschr Geneeskd 1996;140:2164-7.
22. The promise and reality of fixed-dose combinations with rifampicin. A joint statement of the International Union Against Tuberculosis and Lung Disease and the Tuberculosis Programme of the World Health Organization. Tuber Lung Dis 1994;75:180-1.